Clemens M. Doppler

Chairman at 4SC AG

67 year

Commercial Services

Health Technology

Finance

Profile

Clemens M.
Doppler currently serves as Chairman-Supervisory Board at 4SC AG since 2014, Chairman at MerLion Pharmaceuticals Pte Ltd. since 2006, Chairman-Supervisory Board at MerLion Pharmaceuticals GmbH, Managing Director at Heidelbergcapital General Partner GmbH since 2008, Managing Partner at HeidelbergCapital Asset Management GmbH since 2008, and Member at DVFA e.V.
Former positions include Chairman at Accovion GmbH from 2008 to 2015, Vice Chairman-Supervisory Board at Sensovation AG from 2009 to 2013, Business Development Director & Head-department at Phoenix International Life Sciences, Inc. from 1994 to 2000, Director-Business Development & Head-department at Phoenix International Life Sciences, Inc. (Switzerland) from 1994 to 2000, Partner & Director at 3i Deutschland Industriebeteiligungs GmbH, Director at Merlion Trade GmbH, Investment Manager at 3i Group Plc from 2000 to 2007, Investment Manager at Technologie Holding, Member-Supervisory Board at vasopharm GmbH, and Member-Supervisory Board at Nanogate SE.
Education includes graduate and doctorate degrees from Ruprecht-Karls-Universität Heidelberg.

Clemens M. Doppler active positions

Companies	Position	Start
4SC AG	Chairman	2014-09-18
MerLion Pharmaceuticals GmbH MerLion Pharmaceuticals GmbH Miscellaneous Commercial ServicesCommercial Services Engages in research and development of natural sciences, engineering, agricultural sciences and medicine	Chairman	-
Heidelbergcapital General Partner GmbH	Chief Executive Officer	2007-12-31
DVFA e.V.	Corporate Officer/Principal	-
HeidelbergCapital Asset Management GmbH HeidelbergCapital Asset Management GmbH Investment ManagersFinance HCAM is a private equity investment manager specializing in secondary direct investments. They acquire portfolios of minority shareholdings from private equity and venture capital firms as well as investment banks. Their targeted range of investments includes early-stage companies which are already past the startup-phase and have a proven business model, as well as established medium-sized family-owned businesses and small-cap listed companies. They may consider investing in a single company on a case-by-case basis. They are active partners for their portfolio companies, and get involved in strategic decisions. Their strategy includes investing growth capital in the companies in which they have acquired a stake.	Private Equity Investor	2007-12-31

All active positions of Clemens M. Doppler

Former positions of Clemens M. Doppler

Companies	Position	End
Merlion Trade GmbH	Director/Board Member	2021-01-22
Accovion GmbH Accovion GmbH Miscellaneous Commercial ServicesCommercial Services Provides clinical research and development services	Chairman	2014-12-31
Sensovation AG Sensovation AG Electronic Equipment/InstrumentsElectronic Technology Manufactures and markets scientific imaging instrumentation technologies	Director/Board Member	2012-12-31
3I GROUP PLC	Corporate Officer/Principal	2006-12-31
░░░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░ ░░░░░░░░░░░░░	░░░░░░░░░ ░░░░░░░░░░░░░░░░░	░░░░░░░░░░

See the detail of Clemens M. Doppler's experience

Training of Clemens M. Doppler

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Clemens M. Doppler's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	17
Phoenix International Life Sciences, Inc. Phoenix International Life Sciences, Inc. Miscellaneous Commercial ServicesCommercial Services Provides bioanalytical research and clinical testing services	Commercial Services
3i Group Plc 3i Group Plc Investment Trusts/Mutual FundsMiscellaneous Operates as an investment company that specializes in private equity and infrastructure	Miscellaneous
4SC AG 4SC AG BiotechnologyHealth Technology Develops drugs for cancer treatment	Health Technology
3i Deutschland Gesellschaft für Industriebeteiligungen mbH 3i Deutschland Gesellschaft für Industriebeteiligungen mbH Investment ManagersFinance 3i Deutschland is an active manager which aims to invest in small and medium-sized German companies at all stages of development across a range of business sectors. The firm focuses on building partnerships with family-owned businesses, seeking to deliver profitable growth by providing local market understanding, deal experience, broad-based sector expertise and their international network. They introduce investee companies to experienced industrialists and expert advisers, offering perspectives on industry trends and helping to identify new strategies for success and value growth. For venture capital investments, 3i Deutschland invests across a range of businesses from start-ups to established innovators seeking rapid growth, supporting companies at the leading edge in healthcare technology, the consumerization of IT and cleantech. The firm invests growth capital by making minority investments in established, mid-cap, family-owned companies. Their investee businesses use the funds to restructure shareholdings and achieve growth, organically or by acquisition. 3i Deutschland invests in buyouts by acquiring majority holdings in established, mid-cap companies with outstanding management teams and excellent prospects for growth. The firm participates in MBOs, division spin-offs and supporting IPO preparations. They also invest in infrastructure assets, providing structured financing in the transport and logistics, utilities, civil engineering, medicare and public private partnerships sectors.	Finance
Technologie Holding Technologie Holding Financial ConglomeratesFinance Provides Internet investment services	Finance
Accovion GmbH Accovion GmbH Miscellaneous Commercial ServicesCommercial Services Provides clinical research and development services	Commercial Services
vasopharm GmbH vasopharm GmbH Pharmaceuticals: MajorHealth Technology Discovers and develops novel therapeutics for the treatment of cerebro and cardiovascular diseases	Health Technology
Ruprecht-Karls-Universität Heidelberg Ruprecht-Karls-Universität Heidelberg Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Sensovation AG Sensovation AG Electronic Equipment/InstrumentsElectronic Technology Manufactures and markets scientific imaging instrumentation technologies	Electronic Technology
MerLion Pharmaceuticals Pte Ltd. MerLion Pharmaceuticals Pte Ltd. Pharmaceuticals: MajorHealth Technology Develops novel antibiotics	Health Technology
Nanogate SE Nanogate SE Industrial MachineryProducer Manufacturing Designs, develops and produces composite and surface treatments	Producer Manufacturing
HeidelbergCapital Asset Management GmbH HeidelbergCapital Asset Management GmbH Investment ManagersFinance HCAM is a private equity investment manager specializing in secondary direct investments. They acquire portfolios of minority shareholdings from private equity and venture capital firms as well as investment banks. Their targeted range of investments includes early-stage companies which are already past the startup-phase and have a proven business model, as well as established medium-sized family-owned businesses and small-cap listed companies. They may consider investing in a single company on a case-by-case basis. They are active partners for their portfolio companies, and get involved in strategic decisions. Their strategy includes investing growth capital in the companies in which they have acquired a stake.	Finance
Merlion Trade GmbH
DVFA e.V.
MerLion Pharmaceuticals GmbH MerLion Pharmaceuticals GmbH Miscellaneous Commercial ServicesCommercial Services Engages in research and development of natural sciences, engineering, agricultural sciences and medicine	Commercial Services
Heidelbergcapital General Partner GmbH
Phoenix International Life Sciences,Inc. (Switzerland)